Critics of mask-wearing policies used a Danish study on mask-wearing to bolster their claims such policies are ineffective, but scientists, including those involved with the study, disagree.
Category: Editors’ Pick
Mike Pence Falsely Gives Credit To Trump For Pfizer Vaccine Success
Pfizer has repeatedly said its vaccine research and development is “entirely self-funded.”
Sinovac’s Covid-19 Vaccine Appears Safe And Prompts ‘Quick’ Immune Response, Study Finds
Researchers believe the vaccine, which is already approved in China, could be “suitable for emergency use during the pandemic,” though further clinical trials will be needed.
Pfizer-BioNTech Says Covid-19 Vaccine Is 95% Effective, Will Seek Emergency Approval Within Days
It comes after Moderna announced interim data from Phase 3 trials showed its vaccine candidate to be 94.5% effective.
How Much Will A Covid-19 Vaccine Cost?
As Pfizer and Moderna edge closer to regulatory approval, access—and herd immunity—hinges on affordability.
Pfizer To Test Covid-19 Vaccine Delivery Program In Four States
The company hopes to preemptively tackle any distribution problems caused by the ultra-cold storage requirements of the vaccine.
Amazon Turns Up The Heat On Brick-And-Mortar Retailers With New Online Pharmacy
The company will deliver prescriptions to U.S. consumers and offer discounts if paying without insurance.
Amazon Pharmacy Business Adds Online Store, Free Delivery For Prime Members
Amazon is launching a new online store called “Amazon Pharmacy” that allows its U.S. customers to order prescription drugs to their homes with its Prime customers receiving free delivery of their medications.
What You Need To Know About Moderna’s Covid-19 Vaccine
The Boston-based biotech firm is neck and neck with Pfizer in the race to have the first Covid-19 vaccine authorized for use.
Moderna CEO: Covid-19 Vaccine’s ‘Fantastic’ Results Mean It Could Be Ready Next Month
Stéphane Bancel says data showing 95% efficacy for his company’s vaccine means that it may be able to start distributing its vaccine in late December, pending a green light from the FDA.
